[Intervention with selective serotonin reuptake inhibitors (SSRI) in depressed children and adolescents].
Fegert
J M
JM
Herpertz-Dahlmann
B
B
D000293:Adolescent; D016907:Adverse Drug Reaction Reporting Systems / Q000331:legislation & jurisprudence; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003431:Cross-Cultural Comparison; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D017277:Drug Approval; D004363:Drug Utilization / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D005060:Europe; D005858:Germany; D006801:Humans; D012306:Risk; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013406:Suicide, Attempted / Q000706:statistics & numerical data; D014481:United States
D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors